CENTOGENE Reports Fourth Quarter and Full Year 2021 Financia

- Full Year 2021 Total Revenue Growth of 48%, and 11% in Core Business Segments, Exceeds Guidance - Focus on Pharma and Diagnostics to Position for Strong Performance in 2022 - Closed $62 Million... | March 30, 2022

Related Keywords

Germany , Cambridge , Cambridgeshire , United Kingdom , Berlin , Kim Stratton , Miguel Coego , Ben Legg , Lennart Streibel , Alector Inc , Agios Pharmaceuticals , Drug Administration , Company Pharma , Pfizer , Exchange Commission , Company Artificial Intelligence , Corporate Communications , Revenue Growth , Core Business Segments , Strong Performance , Financing Round , Host Conference Call , Chief Executive Officer , Core Business , Interim Chief Financial Officer , Supervisory Board , Andreas Busch , Vice Chairman , Data Access , Collaboration Rd Agreement , Insilico Medicine , Artificial Intelligence , Participant Dial In , Direct Event Passcode , Investor Relations , Centogenenv Stock Exchange , News , Information , Press Release , Bull , Ear , 021 , Total , Revenue , Growth , F , End , N , More , Business , Xceeds , Guidance , Focus , Dharma , Iagnostics , O , Position , Or , Strong , Performance , 022 , Losed Cntg Nl0014040206 ,